SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bayer CropScience slips on reporting 50% fall in Q3 net profit

03 Feb 2016 Evaluate

Bayer CropScience is currently trading at Rs. 3301.85, down by 160.75 points or 4.64% from its previous closing of Rs. 3462.60 on the BSE.

The scrip opened at Rs. 3343.00 and has touched a high and low of Rs. 3343.00 and Rs. 3250.75 respectively.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 4234.00 on 16-Apr-2015 and a 52 week low of Rs. 3192.80 on 27-Mar-2015.

Last one week high and low of the scrip stood at Rs. 3500.65 and Rs. 3250.75 respectively. The current market cap of the company is Rs. 13,041.00 crore.

The promoters holding in the company stood at 68.58 % while Institutions and Non-Institutions held 19.63 % and 11.79 % respectively.

The company has reported 50.18% fall in its net profit at Rs 27.40 crore for the quarter ended December 31, 2015 as compared to Rs 55.00 crore for the same quarter in the previous year. The company’s total income has decreased by 10.19% to Rs 655.00 crore for the quarter under review from Rs 729.30 crore for the corresponding quarter of the previous year. 

Bayer CropScience is engaged in manufacturing and marketing of crop-protection solutions, and trades in seeds on behalf of group company Bayer Bioscience.


Bayer CropScience Share Price

4608.85 -35.05 (-0.75%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
UPL 646.15
PI Industries 3108.10
Bayer CropScience 4608.85
Sharda Cropchem 1121.05
Sumitomo Chemical 485.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×